about
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing dru...
Read More
2.05
0.01
(0.49%)
95,897
XNAS Volume
XNAS 09 Jun, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Lipocine Inc is on 12 Jun 2026 for the purpose of Lipocine Virtual KOL Event
See details
Not Eligible
Expensive Valuation
Technically Bearish
Lipocine Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..